241 related articles for article (PubMed ID: 7979219)
1. Very long chain fatty acids in X-linked adrenoleukodystrophy brain after treatment with Lorenzo's oil.
Poulos A; Gibson R; Sharp P; Beckman K; Grattan-Smith P
Ann Neurol; 1994 Nov; 36(5):741-6. PubMed ID: 7979219
[TBL] [Abstract][Full Text] [Related]
2. Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzo's oil.
Moser HW; Raymond GV; Lu SE; Muenz LR; Moser AB; Xu J; Jones RO; Loes DJ; Melhem ER; Dubey P; Bezman L; Brereton NH; Odone A
Arch Neurol; 2005 Jul; 62(7):1073-80. PubMed ID: 16009761
[TBL] [Abstract][Full Text] [Related]
3. A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy.
Aubourg P; Adamsbaum C; Lavallard-Rousseau MC; Rocchiccioli F; Cartier N; Jambaqué I; Jakobezak C; Lemaitre A; Boureau F; Wolf C
N Engl J Med; 1993 Sep; 329(11):745-52. PubMed ID: 8350883
[TBL] [Abstract][Full Text] [Related]
4. Effect of dietary Lorenzo's oil and docosahexaenoic acid treatment for Zellweger syndrome.
Arai Y; Kitamura Y; Hayashi M; Oshida K; Shimizu T; Yamashiro Y
Congenit Anom (Kyoto); 2008 Dec; 48(4):180-2. PubMed ID: 18983586
[TBL] [Abstract][Full Text] [Related]
5. Lorenzo's oil: a reassessment.
Poulos A; Robertson EF
Med J Aust; 1994 Mar; 160(6):315-7. PubMed ID: 8133809
[No Abstract] [Full Text] [Related]
6. Dietary management of X-linked adrenoleukodystrophy.
Moser HW; Borel J
Annu Rev Nutr; 1995; 15():379-97. PubMed ID: 8527226
[TBL] [Abstract][Full Text] [Related]
7. Lorenzo's oil: advances in the treatment of neurometabolic disorders.
Ferri R; Chance PF
Arch Neurol; 2005 Jul; 62(7):1045-6. PubMed ID: 16009756
[No Abstract] [Full Text] [Related]
8. Early dietary treatments with Lorenzo's oil and docosahexaenoic acid for neurological development in a case with Zellweger syndrome.
Tanaka K; Shimizu T; Ohtsuka Y; Yamashiro Y; Oshida K
Brain Dev; 2007 Oct; 29(9):586-9. PubMed ID: 17418516
[TBL] [Abstract][Full Text] [Related]
9. Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy.
Kemp S; Valianpour F; Denis S; Ofman R; Sanders RJ; Mooyer P; Barth PG; Wanders RJ
Mol Genet Metab; 2005 Feb; 84(2):144-51. PubMed ID: 15670720
[TBL] [Abstract][Full Text] [Related]
10. The effect of Lorenzo's oil on oxidative stress in X-linked adrenoleukodystrophy.
Deon M; Wajner M; Sirtori LR; Fitarelli D; Coelho DM; Sitta A; Barschak AG; Ferreira GC; Haeser A; Giugliani R; Vargas CR
J Neurol Sci; 2006 Sep; 247(2):157-64. PubMed ID: 16750542
[TBL] [Abstract][Full Text] [Related]
11. Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil".
van Geel BM; Assies J; Haverkort EB; Koelman JH; Verbeeten B; Wanders RJ; Barth PG
J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):290-9. PubMed ID: 10449548
[TBL] [Abstract][Full Text] [Related]
12. Brain, liver, and adipose tissue erucic and very long chain fatty acid levels in adrenoleukodystrophy patients treated with glyceryl trierucate and trioleate oils (Lorenzo's oil).
Rasmussen M; Moser AB; Borel J; Khangoora S; Moser HW
Neurochem Res; 1994 Aug; 19(8):1073-82. PubMed ID: 7800117
[TBL] [Abstract][Full Text] [Related]
13. [Endocrine disease in adrenoleukodystrophy].
Girard S; Bruckert E; Turpin G
Ann Med Interne (Paris); 2001 Feb; 152(1):15-26. PubMed ID: 11240421
[TBL] [Abstract][Full Text] [Related]
14. Visual evoked potentials in adrenoleukodystrophy: a trial with glycerol trioleate and Lorenzo oil.
Kaplan PW; Tusa RJ; Shankroff J; Heller J; Moser HW
Ann Neurol; 1993 Aug; 34(2):169-74. PubMed ID: 8338341
[TBL] [Abstract][Full Text] [Related]
15. Treatment of X-linked adrenoleukodystrophy with Lorenzo's oil.
Moser HW
J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):279-80. PubMed ID: 10449544
[No Abstract] [Full Text] [Related]
16. Dietary treatment for X-linked adrenoleukodystrophy: is "Lorenzo's oil" useful?
Prieto Tenreiro A; Penacho Lázaro MÁ; Andrés Celda R; Fernández Fernández M; González Mateo C; Díez Hernández A
Endocrinol Nutr; 2013 Jan; 60(1):37-9. PubMed ID: 22622158
[No Abstract] [Full Text] [Related]
17. Evaluation of the preventive effect of glyceryl trioleate-trierucate ("Lorenzo's oil") therapy in X-linked adrenoleukodystrophy: results of two concurrent trials.
Moser HW; Raymond GV; Koehler W; Sokolowski P; Hanefeld F; Korenke GC; Green A; Loes DJ; Hunneman DH; Jones RO; Lu SE; Uziel G; Giros ML; Roels F
Adv Exp Med Biol; 2003; 544():369-87. PubMed ID: 14713253
[No Abstract] [Full Text] [Related]
18. Adrenoleukodystrophy and the mitochondrial connection: clues for supplementing Lorenzo's oil.
Moraes CT
Brain; 2013 Aug; 136(Pt 8):2339-41. PubMed ID: 23842565
[No Abstract] [Full Text] [Related]
19. Glycerol trioleate/glycerol trierucate therapy in X-linked adrenoleukodystrophy: saturated and unsaturated fatty acids in blood cells. Implications for the follow-up.
Ruiz M; Pampols T; Girós M
J Inherit Metab Dis; 1996; 19(2):188-92. PubMed ID: 8739962
[No Abstract] [Full Text] [Related]
20. Lorenzo's oil and thrombocytopenia in patients with adrenoleukodystrophy.
Zinkham WH; Kickler T; Borel J; Moser HW
N Engl J Med; 1993 Apr; 328(15):1126-7. PubMed ID: 8455677
[No Abstract] [Full Text] [Related]
[Next] [New Search]